Journal List > Ann Clin Microbiol > v.16(2) > 1078468

Kang, Kim, Park, Lim, and Lee: A Case Report of Mycobacterium abscessus Peritonitis in a Patient on Continuous Ambulatory Peritoneal Dialysis

초록

Mycobacterium is an uncommon cause of peritonitis in patients receiving peritoneal dialysis (PD), and the incidence of nontuberculous mycobacterium (NTM) peritonitis is even rarer since the majority of mycobacterial peritonitis cases are caused by Mycobacterium tuberculosis. However, NTM peritonitis has been known to result in a high mortality rate with delayed diagnosis and treatment. In this study, we report a case of Mycobacterium abscessus peritonitis in a 52- year-old male under continuous ambulatory peritoneal dialysis (CAPD).

REFERENCES

1.Brown-Elliott BA., Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002. 15:716–46.
crossref
2.Galil K., Miller LA., Yakrus MA., Wallace RJ Jr., Mosley DG., England B, et al. Abscesses due to Mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis. 1999. 5:681–7.
3.Yim JJ., Oh MD., Yoo CG., Song YW., Kim YW., Seo JW, et al. A case of Mycobacterium abscessus pneumonia in a patient with systemic lupus erythematosus. Tuberc Respir Dis. 1999. 46:96–102.
4.Koh WJ., Kwon OJ., Kang EH., Jeon IS., Pyun YJ., Ham HS, et al. Clinical and radiographic characteristics of 12 patients with Mycobacterium abscessus pulmonary disease. Tuberc Respir Dis. 2003. 54:45–56.
5.Kim HS., Park HJ., Lee JY., Cho BK. Twelve cases of cutaneous infection by Mycobacterium abscessus: Review on its treatment modality. Korean J Dermatol. 2005. 43:1603–9.
6.Jung SY., Na JH., Cho KH., Park JW., Do JY., Yun KW, et al. A case of exit-site infection and abscess by Mycobacterium abscessus in a CAPD patient. Yeungnam Univ J Med. 2009. 26:137–43.
7.Ryoo SW., Shin S., Shim MS., Park YS., Lew WJ., Park SN, et al. Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans. J Clin Lab Anal. 2008. 22:415–20.
crossref
8.Song Y., Wu J., Yan H., Chen J. Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant. 2012. 27:1639–44.
crossref
9.Ding LW., Lai CC., Lee LN., Hsueh PR. Abdominal nontuberculous mycobacterial infection in a university hospital in Taiwan from 1997 to 2003. J Formos Med Assoc. 2006. 105:370–6.
crossref
10.Renaud CJ., Subramanian S., Tambyah PA., Lee EJ. The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: A case series and literature review. Nephrology (Carlton). 2011. 16:174–9.
crossref
11.Rho M., Bia F., Brewster UC. Nontuberculous mycobacterial peritonitis in peritoneal dialysis patients. Semin Dial. 2007. 20:271–6.
12.Kameyama H., Mori Y., Kimura T., Sugishita C., Adachi T., Sono-mura K, et al. A case report of Mycobacterium abscessus peritonitis in a peritoneal dialysis patient. Ther Apher Dial. 2007. 11:449-.

Fig. 1.
Smear of a peritoneal dialysis fluid specimen stained with Ziehl- Neelsen stain (A, ×1,000) and colonies of Mycobacterium abscessus grown on Ogawa medium (B).
acm-16-101f1.tif
Table 1.
Drug susceptibility pattern of M. abscessus isolate
Agent MIC (μ g/mL) Results
Amikacin 16 S
Cefoxitin 32 I
Ciprofloxacin >16 R
Clarithromycin 1,>64 IR
Doxycycline >32 R
Imipenem 8 I
Moxifloxacin 16 R
Trimethoprime/Sulfamethoxazole 16/304 R
Linezolid 8 S

Abbreviations: MIC, minimum inhibitory concentration; S, susce-ptible; I, intermediate resistance; R, resistant; IR, inducible resistance.

TOOLS
Similar articles